Tag: Medicare

Stand-alone Medicare drug plan premiums are rising in 2027 even as the administration touts lower drug prices.

The July 20 memo replaced 2020 and 2024 guidance. Senators asked the agency in August to reinstate the earlier versions.

The increase, the largest since 2023, arrives alongside a projected $6.60 rise in the Medicare Part B premium and a debate over how the adjustment is calculated.

A Slack workspace managed by the Centers for Medicare & Medicaid Services has served as an extraordinary war room for AI industry insiders and Trump administration officials to launch a rapid campaign aimed at persuading Americans to manage their healthcare and medical records on apps.

Democratic senators are pressing the president to say whether he would veto benefit cuts, as the program’s 2032 funding deadline becomes a flashpoint in the fight over retirement security.

Federal officials cite fraud concerns while California leaders warn millions could lose access to critical healthcare and in-home support services.

Internal federal research involving millions of vaccine recipients found rare serious side effects and no major new safety concerns, but agency officials halted publication as critics warn of political interference in public health science.

The proposal would make revenue increases extraordinarily difficult while allowing tax cuts to pass more easily, shifting pressure onto widely used federal programs.

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs.

Federal pilot in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington will pay private A.I. firms a cut of “savings,” prompting warnings of “AI death panels” and the “very worst of private insurance.”